Follicular Lymphoma IV/SC Rituximab Therapy (FLIRT)

NCT02303119 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

221

Enrollment

OTHER

Sponsor class

Conditions

Follicular Lymphoma

Interventions

DRUG: Rituximab IV
DRUG: Rituximab SC

Sponsor

The Lymphoma Academic Research Organisation

Collaborators

[object Object]